FIELD: biotech.
SUBSTANCE: invention relates to the field of biotechnology, namely to nucleic acid molecules that encode the brother of the regulator of imprinted sites (BORIS), an expression vector, BORIS, a vaccine for the treatment and/or prevention of a malignant tumor and treatment of a subject with a BORIS expressing cancer cell. The method includes administering a therapeutically effective amount of a vaccine that contains an effective amount of a vector containing a nucleic acid molecule encoding BORIS containing the amino acid sequence shown in amino acids 55-2040 of SEQ ID NO: 1 or 19-680 of SEQ ID NO: 2.
EFFECT: invention allows expanding the arsenal of technical means.
21 cl, 8 tbl, 9 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BORIS-TARGETED ANTI-CANCER VACCINES AND METHODS FOR APPLICATION THEREOF | 2018 |
|
RU2799786C2 |
| SURVIVIN-TARGETED ANTI-CANCER VACCINES AND APPLICATIONS THEREOF | 2018 |
|
RU2776949C2 |
| ANTI-CANCER VACCINES TARGETED WITH SURVIVIN AND THEIR APPLICATION | 2018 |
|
RU2751253C1 |
| MUC16-TARGETING ANTICANCER VACCINES AND APPLICATION THEREOF | 2018 |
|
RU2777918C2 |
| ANTI-CANCER VACCINES TARGETING MUC16 AND THEIR USE | 2018 |
|
RU2750689C1 |
| ANTI-CANCER VACCINES AIMED AT LEMD1 AND THEIR USE | 2018 |
|
RU2760984C1 |
| ANTI-CANCER VACCINES TARGETING PRAME AND THEIR APPLICATIONS | 2018 |
|
RU2748903C1 |
| MESOTHELINE-TARGETED CANCER VACCINES AND THEIR APPLICATION | 2018 |
|
RU2751252C1 |
| CHIMERIC PROTEIN, A SYNTHETIC DNA WHICH CODES SAID PROTEIN, AN EXPRESSION VECTOR, A SYNTHETIC DNA PRODUCING STRAIN AND A METHOD OF PRODUCING PLASMID DNA | 2016 |
|
RU2736472C2 |
| TOLEROGENIC DNA VACCINE | 2017 |
|
RU2752608C2 |
